ARCHIVES

Two-Month Survival Benefit For Some NSCLC Patients

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology

April 5, 2002

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

April 27, 2012

NCI Moves Slowly, Carcinogenesis CANCERGRAMS For May, June Missing

June 1, 1984

Cancer Control Progress, Challenge Mark ACS Observance

October 18, 1991

FDA Encourages Randomized Trials For Medical Devices.

May 26, 2006

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

August 19, 1994